PharmAla Biotech Holdings on JUNS, Sept 22, 2026
PharmAla Biotech Holdings now owns 17.3%, as a passive investor.
- Date
- Sept 22, 2026
- Who
- PharmAla Biotech Holdings
- Fund
- JUNS - Jupiter Neurosciences
- Stake
- 17.3% (132,867 shares)
- Type of notice
- Passive investor
- Document number
- 0000912282-26-001297
Open the original document at the SEC →
We read this document automatically. If something looks wrong, the original is the one that counts.